Matthew Caufield

Matthew Caufield has a diverse work history in the financial and medical fields. Matthew started their career as a Cancer Research Associate at Rush University Medical Center in 2006 before transitioning to the role of Investment Advisor Representative at North Star Resource Group in 2008. In 2011, they joined JP Morgan Securities LLC as an Investment Service Associate, where they worked until 2013. From 2014 to 2014, they were a Private Bank MBA Summer Associate at JP Morgan Asset Management. Caufield then moved to UBS Financial Services Inc. as a Senior Wealth Strategy Associate from 2015 to 2017. Matthew joined Piper Jaffray in 2017 as an Equity Research Associate and later became an Equity Research Associate, Biotechnology at H.C. Wainwright & Co., LLC in 2018. In 2021, they assumed the position of Vice President, Biotechnology Equity Research at H.C. Wainwright & Co., LLC.

Matthew Caufield's education history includes a Bachelor of Arts (BA) in Neuroscience from Colgate University. Matthew then pursued a Master of Science (MS) degree in Neurobiology from Northwestern University. Currently, it is not specified when they obtained these degrees, as the start and end years are not provided. Additionally, Matthew Caufield has a Master of Business Administration (MBA) from Cornell Johnson Graduate School of Management, but the specific field of study for this degree is not mentioned. In addition to their educational background, Matthew Caufield holds several certifications, including the General Securities Representative, Series 7, Research Analyst Certification, Series 86, Research Analyst Certification, Series 87, and Uniform Combined State Agent/IAR, Series 66. Unfortunately, the specific months and years of obtaining these certifications are not provided.